Literature DB >> 22227901

Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation.

Ying Zhang1, Deli Dong, Baofeng Yang.   

Abstract

Atrial fibrillation (AF) remains one of the leading causes of morbidity and mortality in the world which are related to palpitations, fainting, congestive heart failure or stroke. The mechanism for atrial fibrillation has been identified as electrical remodeling, structure remodeling and intracellular calcium handling remodeling. microRNAs (miRNAs) have recently emerged as one of the important factors in regulating gene expression. So far, thousands of miRNA genes have been found in diverse animals with the function of regulating cell death, cell proliferation, haematopoiesis and even participate in the processing of cardiovascular disease. In this review, we summarize the mechanism of AF and the association of microRNAs network with AF. We provide a potential perspective of miRNAs as the therapeutic target for AF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22227901     DOI: 10.1007/s11427-011-4241-3

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  3 in total

Review 1.  microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.

Authors:  Claudio de Lucia; Klara Komici; Giulia Borghetti; Grazia Daniela Femminella; Leonardo Bencivenga; Alessandro Cannavo; Graziamaria Corbi; Nicola Ferrara; Steven R Houser; Walter J Koch; Giuseppe Rengo
Journal:  Front Med (Lausanne)       Date:  2017-06-12

2.  An altered expression of genes involved in the regulation of ion channels in atrial myocytes is correlated with the risk of atrial fibrillation in patients with heart failure.

Authors:  Mei Gao; Jiangrong Wang; Zhongsu Wang; Yong Zhang; Hui Sun; Xinxing Xie; Yinglong Hou
Journal:  Exp Ther Med       Date:  2013-02-05       Impact factor: 2.447

3.  MicroRNA as a novel player in atrial fibrillation.

Authors:  Siyi Fu; Leqi Huang; Yalong Wang; Xing Li; Jie Li; Junjie Xiao
Journal:  Front Genet       Date:  2014-04-30       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.